1,2,4-oxadiazole derivatives as hPPAR alpha agonists

1,2,4-oxadiazole derivatives as hPPAR alpha agonists

1 2 1 2 33 1-3 3 31-6 4 5 1-3 A compound of formula (I) and pharmaceutically acceptable salts, solvates and hydrolysable esters thereof wherein: Xis O or S; Xis O or S; n is 1-3, One of Y and Z is N, and the other is O; Rand Rare independently halogen, H, CH, OCHor Calkyl; Each Rindependently is hal...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Gellibert, Françoise Jeanne, Liu, Kevin Guangcheng
Format: Patent
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Gellibert, Françoise Jeanne
Liu, Kevin Guangcheng
description 1 2 1 2 33 1-3 3 31-6 4 5 1-3 A compound of formula (I) and pharmaceutically acceptable salts, solvates and hydrolysable esters thereof wherein: Xis O or S; Xis O or S; n is 1-3, One of Y and Z is N, and the other is O; Rand Rare independently halogen, H, CH, OCHor Calkyl; Each Rindependently is halogen, CF, Cstraight or branched alkyl; Rand Rare independently H or Calkyl. y is 0, 1, 2, 3, 4 or 5.
format Patent
fullrecord <record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_07141591</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>07141591</sourcerecordid><originalsourceid>FETCH-uspatents_grants_071415913</originalsourceid><addsrcrecordid>eNrjZDAx1DHSMdHNr0hMyUysys9JVUhJLcosSyzJLEstVkgsVsgICHAMUkjMKchIVEhMz8_LLC4p5mFgTUvMKU7lhdLcDApuriHOHrqlxQWJJal5JcXx6UWJIMrA3NDE0NTS0JgIJQBmaSxw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>1,2,4-oxadiazole derivatives as hPPAR alpha agonists</title><source>USPTO Issued Patents</source><creator>Gellibert, Françoise Jeanne ; Liu, Kevin Guangcheng</creator><creatorcontrib>Gellibert, Françoise Jeanne ; Liu, Kevin Guangcheng ; SmithKline Beecham Corporation</creatorcontrib><description>1 2 1 2 33 1-3 3 31-6 4 5 1-3 A compound of formula (I) and pharmaceutically acceptable salts, solvates and hydrolysable esters thereof wherein: Xis O or S; Xis O or S; n is 1-3, One of Y and Z is N, and the other is O; Rand Rare independently halogen, H, CH, OCHor Calkyl; Each Rindependently is halogen, CF, Cstraight or branched alkyl; Rand Rare independently H or Calkyl. y is 0, 1, 2, 3, 4 or 5.</description><language>eng</language><creationdate>2006</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7141591$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,780,802,885,64039</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7141591$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Gellibert, Françoise Jeanne</creatorcontrib><creatorcontrib>Liu, Kevin Guangcheng</creatorcontrib><creatorcontrib>SmithKline Beecham Corporation</creatorcontrib><title>1,2,4-oxadiazole derivatives as hPPAR alpha agonists</title><description>1 2 1 2 33 1-3 3 31-6 4 5 1-3 A compound of formula (I) and pharmaceutically acceptable salts, solvates and hydrolysable esters thereof wherein: Xis O or S; Xis O or S; n is 1-3, One of Y and Z is N, and the other is O; Rand Rare independently halogen, H, CH, OCHor Calkyl; Each Rindependently is halogen, CF, Cstraight or branched alkyl; Rand Rare independently H or Calkyl. y is 0, 1, 2, 3, 4 or 5.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2006</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNrjZDAx1DHSMdHNr0hMyUysys9JVUhJLcosSyzJLEstVkgsVsgICHAMUkjMKchIVEhMz8_LLC4p5mFgTUvMKU7lhdLcDApuriHOHrqlxQWJJal5JcXx6UWJIMrA3NDE0NTS0JgIJQBmaSxw</recordid><startdate>20061128</startdate><enddate>20061128</enddate><creator>Gellibert, Françoise Jeanne</creator><creator>Liu, Kevin Guangcheng</creator><scope>EFH</scope></search><sort><creationdate>20061128</creationdate><title>1,2,4-oxadiazole derivatives as hPPAR alpha agonists</title><author>Gellibert, Françoise Jeanne ; Liu, Kevin Guangcheng</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_071415913</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2006</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Gellibert, Françoise Jeanne</creatorcontrib><creatorcontrib>Liu, Kevin Guangcheng</creatorcontrib><creatorcontrib>SmithKline Beecham Corporation</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Gellibert, Françoise Jeanne</au><au>Liu, Kevin Guangcheng</au><aucorp>SmithKline Beecham Corporation</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>1,2,4-oxadiazole derivatives as hPPAR alpha agonists</title><date>2006-11-28</date><risdate>2006</risdate><abstract>1 2 1 2 33 1-3 3 31-6 4 5 1-3 A compound of formula (I) and pharmaceutically acceptable salts, solvates and hydrolysable esters thereof wherein: Xis O or S; Xis O or S; n is 1-3, One of Y and Z is N, and the other is O; Rand Rare independently halogen, H, CH, OCHor Calkyl; Each Rindependently is halogen, CF, Cstraight or branched alkyl; Rand Rare independently H or Calkyl. y is 0, 1, 2, 3, 4 or 5.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_uspatents_grants_07141591
source USPTO Issued Patents
title 1,2,4-oxadiazole derivatives as hPPAR alpha agonists
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T08%3A49%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Gellibert,%20Fran%C3%A7oise%20Jeanne&rft.aucorp=SmithKline%20Beecham%20Corporation&rft.date=2006-11-28&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E07141591%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true